Literature DB >> 6016061

Live attenuated mumps-virus vaccine. IV. Protective efficacy as measured in a field evaluation.

M R Hilleman, R E Weibel, E B Buynak, J Stokes, J E Whitman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6016061     DOI： 10.1056/NEJM196702022760502

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  36 in total

1.  Re: V. Usonis et al.: Comparative study of reactogenicity and immunogenicity of new and established measles, mumps and rubella vaccines in healthy children (Infection 26 [1998] 222-226)

Authors:  D Nalin
Journal:  Infection       Date:  1999 Mar-Apr       Impact factor: 3.553

2.  Comparison of a neutralization enzyme immunoassay and an enzyme-linked immunosorbent assay for evaluation of immune status of children vaccinated for mumps.

Authors:  T Harmsen; M C Jongerius; C W van der Zwan; A D Plantinga; C A Kraaijeveld; G A Berbers
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

3.  Routine immunization of adults in Canada: Review of the epidemiology of vaccine-preventable diseases and current recommendations for primary prevention.

Authors:  Michael D Parkins; Shelly A McNeil; Kevin B Laupland
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

4.  Mumps vaccine.

Authors:  J Chin
Journal:  Calif Med       Date:  1973-05

5.  Evaluation of two enzyme immunoassays for detection of immunoglobulin G antibodies to mumps virus.

Authors:  J L Backhouse; H F Gidding; P B McIntyre; G L Gilbert
Journal:  Clin Vaccine Immunol       Date:  2006-07

6.  Estimates of mumps seroprevalence may be influenced by antibody specificity and serologic method.

Authors:  Donald R Latner; Marcia McGrew; Nobia J Williams; Sun B Sowers; William J Bellini; Carole J Hickman
Journal:  Clin Vaccine Immunol       Date:  2013-12-26

7.  Controversies in viral immunization.

Authors:  M A Chernesky
Journal:  Can Fam Physician       Date:  1979-03       Impact factor: 3.275

8.  Outbreak-related mumps vaccine effectiveness among a cohort of children and of young adults in Germany 2011.

Authors:  Anja Takla; Merle M Böhmer; Christina Klinc; Norbert Kurz; Alice Schaffer; Heribert Stich; Petra Stöcker; Ole Wichmann; Judith Koch
Journal:  Hum Vaccin Immunother       Date:  2013-10-07       Impact factor: 3.452

9.  Mumps caused by an inadequately attenuated measles, mumps and rubella vaccine.

Authors:  W Bakker; R Mathias
Journal:  Can J Infect Dis       Date:  2001-05

10.  Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England.

Authors:  Cheryl Cohen; Joanne M White; Emma J Savage; Judith R Glynn; Yoon Choi; Nick Andrews; David Brown; Mary E Ramsay
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.